Spironolactone
Showing 1 - 25 of 376
Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)
Not yet recruiting
- Cardiotoxicity
- +3 more
- Spironolactone
- Placebo
-
São Paulo, BrazilInstituto do Coração
Aug 16, 2023
Alcohol Use Disorder Trial in Baltimore (Spironolactone, Placebo)
Not yet recruiting
- Alcohol Use Disorder
- Spironolactone
- Placebo
-
Baltimore, MarylandNational Institute on Drug Abuse
Apr 10, 2023
Edema Due to Heart Failure or Cirrhosis Trial in Hyderabad, (Spironolactone Oral Suspension)
Completed
- Edema Due to Heart Failure or Cirrhosis
- Spironolactone Oral Suspension
-
Hyderabad,, Telangana, IndiaClinSync Clinical Research Pvt. Ltd.
Aug 28, 2023
Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)
Not yet recruiting
- Dry Eye Disease
- Topical spironolactone ophthalmic solution, 0.005 mg/cc
- Placebo
-
Bellaire, TexasRichard W Yee, MD PLLC
Aug 16, 2023
Rheumatoid Arthritis Trial in Strasbourg (Spironolactone, Placebo)
Recruiting
- Rheumatoid Arthritis
- Spironolactone
- Placebo
-
Strasbourg, Alsace, FranceUniversity Hospital, Strasbourg, France
Aug 17, 2022
Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- Finerenone
- Spironolactone
- (no location specified)
Apr 3, 2023
Resistant Hypertension Trial in Seoul (Spironolactone, Amiloride)
Recruiting
- Resistant Hypertension
- Spironolactone
- Amiloride
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital, Yonsei University Health Syst
Jul 28, 2022
Heart Failure With Preserved Ejection Fraction Trial in Porto (Dapagliflozin, Spironolactone, Spironolactone + Dapagliflozin)
Recruiting
- Heart Failure With Preserved Ejection Fraction
- Dapagliflozin
- +2 more
-
Porto, Portugal
- +1 more
Jan 12, 2023
NASH - Nonalcoholic Steatohepatitis Trial in San Francisco (Spironolactone 100mg, Placebo oral capsule)
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- Spironolactone 100mg
- Placebo oral capsule
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 9, 2022
Polycystic Ovary Syndrome, Puberty Disorders, Ovulation Disorder Trial in Charlottesville (Spironolactone)
Recruiting
- Polycystic Ovary Syndrome
- +2 more
- Spironolactone
-
Charlottesville, VirginiaUniversity of Virginia Center for Research in Reproduction
Jul 28, 2022
Hyperandrogenism, Polycystic Ovary Syndrome, Puberty Trial in Charlottesville (Spironolactone, Placebo)
Recruiting
- Hyperandrogenism
- +2 more
- Spironolactone
- Placebo
-
Charlottesville, VirginiaCenter for Research in Reproduction, University of Virginia
Jul 28, 2022
Primary Aldosteronism Trial (Super selective adrenal artery embolization, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Super selective adrenal artery embolization
- Spironolactone
- (no location specified)
Aug 12, 2022
Transgender Health, Gender Dysphoria, Transgender Women Trial in Philadelphia (Doravirine/Lamivudine/Tenofovir, Spironolactone
Completed
- Transgender Health
- +3 more
- Doravirine/Lamivudine/Tenofovir
- +3 more
-
Philadelphia, PennsylvaniaClinical Research Unit at Thomas Jefferson University
Feb 1, 2023
Diabetic Maculopathy Trial in Winston-Salem (Spironolactone 50 mg)
Withdrawn
- Diabetic Maculopathy
- Spironolactone 50 mg
-
Winston-Salem, North CarolinaWake Forest Baptist Health
Jul 28, 2022
Intracerebral Hemorrhage, Spironolactone Trial in New Haven, Winston-Salem, Philadelphia (Spironolactone Pill)
Recruiting
- Intracerebral Hemorrhage
- Spironolactone
- Spironolactone Pill
-
New Haven, Connecticut
- +4 more
Nov 22, 2022
Renal Insufficiency, Chronic Hypertension Trial in Indianapolis (Spironolactone, Chlorthalidone, Placebo)
Recruiting
- Renal Insufficiency
- Chronic Hypertension
- Spironolactone
- +2 more
-
Indianapolis, IndianaRichard L Roudebush VA Medical Center
Feb 1, 2022
Heart Failure, Type 2 Diabetes, Glucose Intolerance Trial in Montreal (Eplerenone, Spironolactone)
Completed
- Heart Failure
- +2 more
- Eplerenone
- Spironolactone
-
Montreal, Quebec, CanadaMontreal Heart Institute
Oct 5, 2022
Muscular Dystrophy, Duchenne Trial in United States (Spironolactone, Prednisolone)
Terminated
- Muscular Dystrophy, Duchenne
- Spironolactone
- Prednisolone
-
Iowa City, Iowa
- +3 more
Jan 19, 2022
Hyperandrogenism, Polycystic Ovary Syndrome, Puberty Trial in Charlottesville (Micronized progesterone, Spironolactone, Placebo)
Recruiting
- Hyperandrogenism
- +2 more
- Micronized progesterone
- +2 more
-
Charlottesville, VirginiaUniversity of Virginia Clinical Research Unit
May 16, 2022
Polycystic Ovary Syndrome (PCOS) Trial in Worldwide (Placebo, Pioglitazone, Spironolactone)
Recruiting
- Polycystic Ovary Syndrome (PCOS)
- Placebo
- +3 more
-
Graz, Austria
- +6 more
Jul 6, 2022
Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2 Trial in Lawrenceville, Bethlehem (Renin-Angiotensin (RAAS) alone,
Recruiting
- Renal Insufficiency, Chronic
- Diabetic Nephropathy Type 2
- Renin-Angiotensin (RAAS) alone
- Renin-Angiotensin (RAAS) blockers in combination with Spironolactone
-
Lawrenceville, Georgia
- +1 more
Jan 26, 2022
Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)
Recruiting
- Neuroblastoma Recurrent
- Natural killer cell
- +4 more
-
Hong Kong, Hong KongHong Kong Children's Hospital
Feb 22, 2023
Respiratory Distress Syndrome, Adult Trial in Istanbul (Spironolactone 100mg, Placebo oral tablet)
Completed
- Respiratory Distress Syndrome, Adult
- Spironolactone 100mg
- Placebo oral tablet
-
Istanbul, TurkeyIstanbul University-Cerrahpaşa
Oct 21, 2021
Resistant Hypertension Trial in Guangzhou (Sacubitril/valsartan, valsartan)
Recruiting
- Resistant Hypertension
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Sep 16, 2022